Diethylamine

Diethylamine

SCHEMBL479076

CCCl.CCNCC.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylamine SCHEMBL981472 0.96
Diethylamine SCHEMBL28282252 0.92
Diethylamine SCHEMBL3213311 0.87
Diethylamine SCHEMBL29019634 0.87
Diethylamine SCHEMBL1332127 0.87
Diethylamine SCHEMBL5321340 0.87
Diethylamine SCHEMBL9701034 0.87
Diethylamine SCHEMBL124914 0.87
Diethylamine SCHEMBL2869417 0.87 TP53 (0.89)
Diethylamine SCHEMBL19856521 0.87 TP53 (0.89)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113956240-B Pyrimidine derivatives and application thereof in preparing antitumor drugs 陕西师范大学 2023-02-14 CN disclosed
CN-113956240-A Pyrimidine derivatives and application thereof in preparing antitumor drugs 陕西师范大学 2022-01-21 CN disclosed
CN-105873565-B Personal care compositions containing modified guar derivatives 陶氏环球技术有限责任公司 2020-04-14 CN disclosed
US-8137548-B2 Chelator-modified inorganic oxide particles ZIRCHROM SEPARATIONS, INC. (US) 2012-03-20 US disclosed
EP-2410980-A2 AMINATED POLYMERS AND THEIR USE IN WATER-BORNE COMPOSITIONS Hercules Incorporated (US) 2012-02-01 EP disclosed
US-8076488-B2 Antiproliferative agents; angiogenesis inhibitors; anticancer agents BAYER HEALTHCARE LLC (US) 2011-12-13 US disclosed
WO-2010111576-A2 AMINATED POLYMERS AND THEIR USE IN WATER-BORNE COMPOSITIONS HERCULES INCORPORATED (US) 2010-09-30 WO disclosed
CN-100404508-C Tetrahydroquinoline derivatives AKZO NOBEL NV (NL) 2008-07-23 CN disclosed
CN-1729175-A Tetrahydroquinoline derivatives AKZO NOBEL NV (NL) 2006-02-01 CN disclosed
EP-1608639-A2 NOVEL BICYCLIC UREA DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS Bayer Pharmaceuticals Corporation (US) 2005-12-28 EP disclosed
US-RE30379-E ANTIVIRAL ACTIVITY STRATEGIC MEDICAL RESEARCH CORP. (US) 1980-08-19 US disclosed
US-RE30354-E VIRICIDES STRATEGIC MEDICAL RESEARCH CORP. (US) 1980-07-29 US disclosed
US-4124603-A ANTIMICROBIAL RIKER LABORATORIES, INC. (US) 1978-11-07 US disclosed
US-4067993-A Antimicrobial 2-nitro-3-phenylbenzofurancarboxylic acids RIKER LABORATORIES, INC. (US) 1978-01-10 US disclosed
US-4056322-A Preparation of ethers of monosaccharides STRATEGIC MEDICAL RESEARCH CORPORATION (US) 1977-11-01 US disclosed
US-4017608-A VIRICIDES STRATEGIC MEDICAL RESEARCH CORPORATION (US) 1977-04-12 US disclosed
US-4016261-A VIRICIDE MONOSACCHARIDES STRATEGIC MEDICAL RESEARCH CORPORATION (US) 1977-04-05 US disclosed
US-3965262-A OR MEMORY IN WARM BLOODED ANIMALSMONOSACCHARIDE DERIVATIVES STRATEGIC MEDICAL RESEARCH CORPORATION (US) 1976-06-22 US disclosed
US-3939146-A VIRICIDE STRATEGIC MEDICAL RESEARCH CORPORATION (US) 1976-02-17 US disclosed
US-3939145-A VIRICIDE STRATEGIC MEDICAL RESEARCH CORPORATION (US) 1976-02-17 US disclosed